Sfoglia per Rivista HEALTH POLICY
Mostrati risultati da 1 a 14 di 14
Artificial Neural Network and risk stratification models in Emergency Departments: the policy maker's perspective
2016-01-01 Casagranda, I; Costantino, G; Falavigna, G; Furlan, R; Ippoliti, R
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency
2019-01-01 Villa, F.; Tutone, M.; Altamura, G.; Antignani, S.; Cangini, A.; Fortino, I.; Melazzini, M.; Trotta, F.; Tafuri, G.; Jommi, C.
Multi-tier drugs assessment in a decentralised health care system. The Italian case-study
2013-01-01 Jommi, Claudio; E., Costa; A., Michelon; M., Pisacane; G., Scroccaro
Pharmaceutical companies and Italian Regional Governments: Managing relationships in an increasing institutional complexity
2008-01-01 Compagni, A.; Cavalli, L.; Jommi, Claudio
Pharmaceutical companies and Italian Regional Governments: Managing relationships in an increasing institutional complexity
2008-01-01 Compagni, A.; Cavalli, L.; Jommi, Claudio
Public administration and R&D localisation by pharmaceutical and biotech companies: A theoretical framework and the Italian case-study
2007-01-01 Jommi, Claudio; S., Paruzzolo
Public administration and R&D localisation by pharmaceutical and biotech companies: A theoretical framework and the Italian case-study
2007-01-01 Jommi, Claudio; S., Paruzzolo
Quasi-market and cost-containment in Beveridge systems:The Lombardy model of Italy
2011-01-01 Brenna, Elenka
Should I care for my mum or for my kid? Sandwich generation and depression burden in Italy
2020-01-01 Brenna, E.
Stakeholders involvement by HTA Organisations: Why is so different?
2012-01-01 Marianna, Cavazza; Jommi, Claudio
Stakeholders involvement by HTA Organisations: Why is so different?
2012-01-01 Marianna, Cavazza; Jommi, Claudio
Stakeholders involvement by HTA Organisations: why is so different?
2012-01-01 Cavazza, M; Jommi, Claudio
The last decade of Italian pharmaceutical policy: instability or consolidation?
2008-01-01 Fattore, G; Jommi, Claudio
Variations in non-prescription drug consumption and expenditure: Determinants and policy implications
2018-01-01 Otto, M.; Armeni, P.; Jommi, C.
Mostrati risultati da 1 a 14 di 14
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile